Differential effects of triptolide and tetrandrine on activation of COX-2, NF-κB, and AP-1 and virus production in dengue virus-infected human lung cells

European Journal of Pharmacology

Volumn 589, Issue 1-3, 2008, Pages 288-298

  Liou, Jun Ting ^a   Chen, Zih Yan ^b   Ho, Ling Jun ^c   Yang, Shih Ping ^a   Chang, Deh Ming ^a   Liang, Chun Chin ^c   Lai, Jenn Haung ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

A549 cell; AP 1; COX 2; Dengue virus; NF B; PGE2; Tetrandrine; Triptolide

Indexed keywords

CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROSTAGLANDIN E2; TETRANDRINE; TRANSCRIPTION FACTOR AP 1; TRIPTOLIDE;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENGUE VIRUS; DRUG SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS INHIBITION;

ANTI-INFLAMMATORY AGENTS; ANTIVIRAL AGENTS; BENZYLISOQUINOLINES; CELL LINE, TUMOR; CYCLOOXYGENASE 2; DENDRITIC CELLS; DENGUE VIRUS; DINOPROSTONE; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; EPOXY COMPOUNDS; HUMANS; IMMUNOLOGIC FACTORS; LIVER; LUNG; NF-KAPPA B; PHENANTHRENES; TIME FACTORS; TRANSCRIPTION FACTOR AP-1; VIRUS REPLICATION;

EID: 47749118331     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.04.056     Document Type: Article

References (65)

1. Brinker A.M., Ma J., Lipsky P.E., and Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68 (2007) 732-766
2. Carey M.A., Bradbury J.A., Seubert J.M., Langenbach R., Zeldin D.C., and Germolec D.R. Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection. J. Immunol. 175 (2005) 6878-6884
3. Chen C.J., Raung S.L., Kuo M.D., and Wang Y.M. Suppression of Japanese encephalitis virus infection by non-steroidal anti-inflammatory drugs. J. Gen. Virol. 83 (2002) 1897-1905
4. Chun K.S., and Surh Y.J. Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem. Pharmacol. 68 (2004) 1089-1100
5. Dai Y.Q., Jin D.Z., Zhu X.Z., and Lei D.L. Triptolide inhibits COX-2 expression via NF-kappa B pathway in astrocytes. Neurosci. Res. 55 (2006) 154-160
6. De Bosscher K., Vanden Berghe W., and Haegeman G. The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocr. Rev. 24 (2003) 488-522
7. de Moraes E., Dar N.A., de Moura Gallo C.V., and Hainaut P. Cross-talks between cyclooxygenase-2 and tumor suppressor protein p53: balancing life and death during inflammatory stress and carcinogenesis. Int. J. Cancer 121 (2007) 929-937
8. Dong Z., Huang C., Brown R.E., and Ma W.Y. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin. J. Biol. Chem. 272 (1997) 9962-9970
9. Gualde N., and Harizi H. Prostanoids and their receptors that modulate dendritic cell-mediated immunity. Immunol. Cell Biol. 82 (2004) 353-360
10. Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20 (2001) 2465-2475
11. Hiscott J., Nguyen T.L., Arguello M., Nakhaei P., and Paz S. Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses. Oncogene 25 (2006) 6844-6867
12. Ho L.J., and Lai J.H. Chinese herbs as immunomodulators and potential disease-modifying antirheumatic drugs in autoimmune disorders. Curr. Drug Metab. 5 (2004) 181-192
13. Ho L.J., Chang D.M., Shiau H.Y., Chen C.H., Hsieh T.Y., Hsu Y.L., Wong C.S., and Lai J.H. Aspirin differentially regulates endotoxin-induced IL-12 and TNF-alpha production in human dendritic cells. Scand. J. Rheumatol. 30 (2001) 346-352
14. Ho L.J., Wang J.J., Shaio M.F., Kao C.L., Chang D.M., Han S.W., and Lai J.H. Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 166 (2001) 1499-1506
15. Ho L.J., Juan T.Y., Chao P., Wu W.L., Chang D.M., Chang S.Y., and Lai J.H. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell. Br. J. Pharmacol. 143 (2004) 919-927
16. Ho L.J., Hung L.F., Weng C.Y., Wu W.L., Chou P., Lin Y.L., Chang D.M., Tai T.Y., and Lai J.H. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 174 (2005) 8163-8172
17. Hooks J.J., Chin M.S., Srinivasan K., Momma Y., Hooper L.C., Nagineni C.N., Chan C.C., and Detrick B. Human cytomegalovirus induced cyclooxygenase-2 in human retinal pigment epithelial cells augments viral replication through a prostaglandin pathway. Microbes Infect. 8 (2006) 2236-2244
18. Iniguez M.A., Martinez-Martinez S., Punzon C., Redondo J.M., and Fresno M. An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J. Biol. Chem. 275 (2000) 23627-23635
19. Jassim S.A., and Naji M.A. Novel antiviral agents: a medicinal plant perspective. J. Appl. Microbiol. 95 (2003) 412-427
20. Jiang X.H., Wong B.C., Lin M.C., Zhu G.H., Kung H.F., Jiang S.H., Yang D., and Lam S.K. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 20 (2001) 8009-8018
21. Karin M., Liu Z., and Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9 (1997) 240-246
22. Khyatti M., and Menezes J. The effect of indomethacin, prostaglandin E2 and interferon on the multiplication of herpes simplex virus type 1 in human lymphoid cells. Antivir. Res. 14 (1990) 161-172
23. Kopp E., and Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265 (1994) 956-959
24. Krakauer T., Chen X., Howard O.M., and Young H.A. Triptolide attenuates endotoxin- and staphylococcal exotoxin-induced T-cell proliferation and production of cytokines and chemokines. Immunopharmacol. Immunotoxicol. 27 (2005) 53-66
25. Lai J.H., Ho L.J., Kwan C.Y., Chang D.M., and Lee T.C. Plant alkaloid tetrandrine and its analog block CD28-costimulated activities of human peripheral blood T cells: potential immunosuppressants in transplantation immunology. Transplantation 68 (1999) 1383-1392
26. Lai J.H., Ho L.J., Lu K.C., Chang D.M., Shaio M.F., and Han S.H. Western and Chinese antirheumatic drug-induced T cell apoptotic DNA damage uses different caspase cascades and is independent of Fas/Fas ligand interaction. J. Immunol. 166 (2001) 6914-6924
27. Lara-Pezzi E., Gomez-Gaviro M.V., Galvez B.G., Mira E., Iniguez M.A., Fresno M., Martinez A.C., Arroyo A.G., and Lopez-Cabrera M. The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J. Clin. Invest. 110 (2002) 1831-1838
28. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev., Immunol. 2 (2002) 787-795
29. Lee Y.R., Su C.Y., Chow N.H., Lai W.W., Lei H.Y., Chang C.L., Chang T.Y., Chen S.H., Lin Y.S., Yeh T.M., and Liu H.S. Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES. Virus Res. 126 (2007) 216-225
30. Liao C.L., Lin Y.L., Wu B.C., Tsao C.H., Wang M.C., Liu C.I., Huang Y.L., Chen J.H., Wang J.P., and Chen L.K. Salicylates inhibit flavivirus replication independently of blocking nuclear factor kappa B activation. J. Virol. 75 (2001) 7828-7839
31. Lin C.F., Wan S.W., Cheng H.J., Lei H.Y., and Lin Y.S. Autoimmune pathogenesis in dengue virus infection. Viral Immunol. 19 (2006) 127-132
32. Liu T., Zaman W., Kaphalia B.S., Ansari G.A., Garofalo R.P., and Casola A. RSV-induced prostaglandin E2 production occurs via cPLA2 activation: role in viral replication. Virology 343 (2005) 12-24
33. Liu Q., Chen T., Chen G., Li N., Wang J., Ma P., and Cao X. Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation. Biochem. Biophys. Res. Commun. 345 (2006) 1122-1130
34. Liu Q., Chen T., Chen G., Shu X., Sun A., Ma P., Lu L., and Cao X. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-kappaB pathways. Mol. Immunol. 44 (2007) 2686-2696
35. Marcet B., Libert F., Boeynaems J.M., and Communi D. Extracellular nucleotides induce COX-2 up-regulation and prostaglandin E2 production in human A549 alveolar type II epithelial cells. Eur. J. Pharmacol. 566 (2007) 167-171
36. Martin K.W., and Ernst E. Antiviral agents from plants and herbs: a systematic review. Antivir. Ther. 8 (2003) 77-90
37. Moriuchi M., Inoue H., and Moriuchi H. Reciprocal interactions between human T-lymphotropic virus type 1 and prostaglandins: implications for viral transmission. J. Virol. 75 (2001) 192-198
38. Pang L., and Hoult J.R. Cytotoxicity to macrophages of tetrandrine, an antisilicosis alkaloid, accompanied by an overproduction of prostaglandins. Biochem. Pharmacol. 53 (1997) 773-782
39. Park G.Y., and Christman J.W. Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases. Am. J. Physiol., Lung Cell. Mol. Physiol. 290 (2006) L797-L805
40. Phipps R.P., Stein S.H., and Roper R.L. A new view of prostaglandin E regulation of the immune response. Immunol. Today 12 (1991) 349-352
41. Primache V., Binda S., De Benedittis G., and Barbi M. In vitro activity of acetylsalicylic acid on replication of varicella-zoster virus. New Microbiol. 21 (1998) 397-401
42. Qiu D., Zhao G., Aoki Y., Shi L., Uyei A., Nazarian S., Ng J.C., and Kao P.N. Immunosuppressant PG490 (triptolide) inhibits T-cell interleukin-2 expression at the level of purine-box/nuclear factor of activated T-cells and NF-kappaB transcriptional activation. J. Biol. Chem. 274 (1999) 13443-13450
43. Raaben M., Einerhand A.W., Taminiau L.J., van Houdt M., Bouma J., Raatgeep R.H., Buller H.A., de Haan C.A., and Rossen J.W. Cyclooxygenase activity is important for efficient replication of mouse hepatitis virus at an early stage of infection. Virol. J. 4 (2007) 55
44. Ray N., Bisher M.E., and Enquist L.W. Cyclooxygenase-1 and -2 are required for production of infectious pseudorabies virus. J. Virol. 78 (2004) 12964-12974
45. Reynolds A.E., and Enquist L.W. Biological interactions between herpesviruses and cyclooxygenase enzymes. Rev. Med. Virol. 16 (2006) 393-403
46. Richardson J.Y., Ottolini M.G., Pletneva L., Boukhvalova M., Zhang S., Vogel S.N., Prince G.A., and Blanco J.C. Respiratory syncytial virus (RSV) infection induces cyclooxygenase 2: a potential target for RSV therapy. J. Immunol. 174 (2005) 4356-4364
47. Rocca B., and FitzGerald G.A. Cyclooxygenases and prostaglandins: shaping up the immune response. Int. Immunopharmacol. 2 (2002) 603-630
48. Rossen J.W., Bouma J., Raatgeep R.H., Buller H.A., and Einerhand A.W. Inhibition of cyclooxygenase activity reduces rotavirus infection at a postbinding step. J. Virol. 78 (2004) 9721-9730
49. Sadowska B., Barrucco R., Khalili K., and Safak M. Regulation of human polyomavirus JC virus gene transcription by AP-1 in glial cells. J. Virol. 77 (2003) 665-672
50. Santoro M.G., Rossi A., and Amici C. NF-kappaB and virus infection: who controls whom. EMBO J. 22 (2003) 2552-2560
51. Sarkar F.H., Adsule S., Li Y., and Padhye S. Back to the future: COX-2 inhibitors for chemoprevention and cancer therapy. Mini Rev. Med. Chem. 7 (2007) 599-608
52. Savard M., Belanger C., Tremblay M.J., Dumais N., Flamand L., Borgeat P., and Gosselin J. EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J. Immunol. 164 (2000) 6467-6473
53. Sharma-Walia N., Raghu H., Sadagopan S., Sivakumar R., Veettil M.V., Naranatt P.P., Smith M.M., and Chandran B. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J. Virol. 80 (2006) 6534-6552
54. Speir E., Yu Z.X., Ferrans V.J., Huang E.S., and Epstein S.E. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells. Circ. Res. 83 (1998) 210-216
55. Steer S.A., and Corbett J.A. The role and regulation of COX-2 during viral infection. Viral Immunol. 16 (2003) 447-460
56. Tao X., Schulze-Koops H., Ma L., Cai J., Mao Y., and Lipsky P.E. Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production. Arthritis Rheum. 41 (1998) 130-138
57. Tsatsanis C., Androulidaki A., Venihaki M., and Margioris A.N. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38 (2006) 1654-1661
58. Wachsman M., Aurelian L., and Burnett J.W. The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections. Br. J. Dermatol. 123 (1990) 375-380
59. Waris G., and Siddiqui A. Hepatitis C virus stimulates the expression of cyclooxygenase-2 via oxidative stress: role of prostaglandin E2 in RNA replication. J. Virol. 79 (2005) 9725-9734
60. Watkins D.N., Peroni D.J., Lenzo J.C., Knight D.A., Garlepp M.J., and Thompson P.J. Expression and localization of COX-2 in human airways and cultured airway epithelial cells. Eur. Respir. J. 13 (1999) 999-1007
61. Williams C.S., Mann M., and DuBois R.N. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 (1999) 7908-7916
62. Wu S.J., and Ng L.T. Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol. Pharm. Bull. 30 (2007) 59-62
63. Yang S.P., Ho L.J., Lin Y.L., Cheng S.M., Tsao T.P., Chang D.M., Hsu Y.L., Shih C.Y., Juan T.Y., and Lai J.H. Carvedilol, a new antioxidative beta-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-kappaB activity. Cardiovasc. Res. 59 (2003) 776-787
64. Zhang H., Li Y.Y., and Wu X.Z. Effect of tetrandrine on LPS-induced NF-kappaB activation in isolated pancreatic acinar cells of rat. World J. Gastroenterol. 12 (2006) 4232-4236
65. Zhong B., Tien P., and Shu H.B. Innate immune responses: crosstalk of signaling and regulation of gene transcription. Virology 352 (2006) 14-21